The Rise Funds announced on June 1 that it made a significant investment in Banyan Treatment Centers.
Moelis & Company served as exclusive financial advisor to Banyan Treatment Centers. Terms of the investment were not disclosed.
Founded in 2013, Banyan offers a full continuum-of-care for patients suffering from addiction. Banyan provides clinical outcomes across medically monitored detox, residential, partial hospitalization, intensive outpatient and telemedicine services. Per its website, it operates across 16 facilities in eight states.
The Rise Funds are a core pillar of TPG Rise, TPG‘s global impact investing platform. Founded in 2016 by TPG in partnership with Bono and Jeff Skoll, The Rise Funds invest behind impact entrepreneurs and growth-stage, high potential, mission-driven companies that are focused on achieving the United Nations’ Sustainable Development Goals. With approximately $17 billion in assets across The Rise Funds, TPG Rise Climate and the Evercare Health Fund, the TPG Rise platform is one of the world’s largest private markets impact investing platforms.
According to data captured in the LevinPro HC database, this transaction marks the 33rd Behavioral Health Care acquisition of the year, and eighth in the substance use disorder specialty. This is The Rise Funds’ first acquisition of the year and follows its 2022 purchase of Blue Cloud Pediatric Surgery Centers.
